ENTITY
Hangzhou Tigermed Consulting (A)

Hangzhou Tigermed Consulting (A) (300347 CH)

96
Analysis
Health CareChina
Hangzhou Tigermed Consulting Company Limited provides professional clinical research services for domestic and foreign pharmaceutical and health-related research and development. The Company's main services include clinical trial technology services, data management, and statistical analysis.
more
Refresh
15 May 2019 15:03

Frontage Holdings (方达控股) IPO: Reasonable Valuation & Quality Cornerstones

Frontage Holdings, a pre-clinical CRO arm of A-share listed Hangzhou Tigermed Consulting (300347 CH), started book building today to raise up to...

Logo
793 Views
Share
08 May 2019 15:36

Frontage Holdings IPO Preview: An Uncertain Transition

Frontage Laboratories Inc (1000371Z HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347...

Logo
673 Views
Share
20 Mar 2019 16:23

Frontage Holding (方达控股) IPO: Updates from 2018 Numbers

Frontage Holding, a contract research organization subsidiary of A-share listed Hangzhou Tigermed Consulting (300347 CH), re-filed to list on the...

Logo
759 Views
Share
03 Jan 2019 10:23

Discover SZ/​SH Connect: Foreigners Were Buying Industries and Financials in December

In our Discover SZ/SH Connect series, we aim to help our investors understand the flow of northbound trades via the Shanghai Connect and Shenzhen...

Logo
557 Views
Share
bearishWuXi AppTec
11 Dec 2018 19:57

WuXi AppTec IPO Valuation: Bull/​Bear Case DCF Scenarios

WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....

Logo
511 Views
Share
x